SAC Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-33,757
Closed -$1.99M 572
2014
Q1
$1.99M Buy
33,757
+7,582
+29% +$423K 0.01% 764
2013
Q4
$1.33M Sell
26,175
-131,784
-83% -$6.6M 0.01% 819
2013
Q3
$7.95M Sell
157,959
-30,455
-16% -$1.59M 0.04% 436
2013
Q2
$9.26M Buy
+188,414
New +$10.3M 0.05% 385

Other funds holding LLY

SAC Capital Advisors's LLY Position: Q2 2014 in Review

SAC Capital Advisors sold out of Eli Lilly (LLY) in Q2 2014, closing a stake of 33,757 shares — an estimated $1.99M sold.

SAC Capital Advisors first reported a position in LLY in Q2 2013 and held it in 4 quarters. The position peaked at $9.26M in Q2 2013. 1,028 funds tracked by Wall St. Rank hold LLY as of Q2 2014.

  • SAC Capital Advisors reported no remaining Eli Lilly position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 33,757 Eli Lilly shares in Q2 2014, an estimated $1.99M.
  • SAC Capital Advisors first reported a position in Eli Lilly in Q2 2013 and held it in 4 quarters.
  • SAC Capital Advisors's Eli Lilly position peaked at $9.26M in Q2 2013.
  • 1,028 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.